Study number 8539-627
Dates
Sep 22 2025-Nov 04 2025
Location
Daytona Beach, Florida
Age
18-65
Gender
Male or Female
Smoker
No
Compensation
$11,228
Group
Part 2 Group 3a OR 3b
This is a research study for an investigational drug being developed for the treatment of Primary Sjögren’s Syndrome, an autoimmune disorder in which the immune system mistakenly attacks healthy cells in the body.
Fortrea Daytona Beach, FL is recruiting for:
- Healthy Non-Smoking Adults, age 18-65
- Body Mass Index between 18.5-30
- Study involves 1 stay of 18 overnights & 1 follow-up visit*& 1 phone call
- Compensation up to $11,228 may be provided for time and participation*
- Refer a friend to receive $350 per qualified referral
*Additional out-patient visits may be required at the end of the study, resulting in additional compensation of up to
$174 per additional visit.
Call Now to Schedule Your Screening Appointment!
Part 2 Group 3a:
Check-in: Sep 22
Check-out: Oct 10
Follow up Visit: Oct 18
Phone Call: Nov 4
OR
Part 2 Group 3b:
Check-in: Sep 24
Check-out: Oct 12
Follow up Visit: Oct 20
Phone Call: Nov 6